Korro Bio (KRRO) Other financing activities (2018 - 2026)
Korro Bio's (KRRO) quarterly Other financing activities came in at $17000.0 in Q1 2026, down 97.52% on a QoQ basis from $685000.0 in Q4 2025.
Korro Bio (KRRO) Other financing activities (2018 - 2026) Analysis & Trends
Korro Bio (KRRO) has 8 years of Other financing activities data on file, last reported at $17000.0 in Q1 2026.
- Quarterly Other financing activities changed N/A year-over-year to $17000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $702000.0 (down 99.58% YoY) and the FY2025 annual result came in at $685000.0, down 98.98% from the prior year.
- Other financing activities slipped to $17000.0 in Q1 2026, from $685000.0 in the prior quarter.
- In the past five years, Other financing activities ranged from a high of $100.0 million in Q4 2024 to a low of -$351000.0 in Q4 2023.
- A 5-year average of $12.0 million and a median of $139000.0 in 2022 frame the typical range for Other financing activities.
- Annual changes were most pronounced in 2022 — Other financing activities tumbled 13300.0% — and 2024, when it jumped 28590.03%.
- Tracing KRRO's Other financing activities over 5 years: stood at -$134000.0 in 2022, then slumped by 161.94% to -$351000.0 in 2023, then jumped by 28590.03% to $100.0 million in 2024, then tumbled by 99.32% to $685000.0 in 2025, then tumbled by 97.52% to $17000.0 in 2026.
- The last three Other financing activities figures came in at $17000.0 (Q1 2026), $685000.0 (Q4 2025), and -$177000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.50 Bn | 131.65 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 86.10 Bn | 78.10 Bn | 3.93 Bn |
| 3 | Argenx Se | 65.59 Bn | 60.41 Bn | 1.37 Bn |
| 4 | Moderna | 56.75 Bn | 51.62 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 42.11 Bn | 37.01 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.64 Bn | 28.33 Bn | 992.69 Mn |
| 7 | BioNTech SE | 27.80 Bn | 9.41 Bn | 668.28 Mn |
| 8 | Insmed | 27.51 Bn | 26.35 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.29 Bn | 26.45 Bn | - |
| 10 | Korro Bio | 233.44 Mn | 118.41 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -21,000.00 |
| Jun 30, 2026 | -21,000.00 |
| Mar 31, 2026 | 17,000.00 |
| Mar 31, 2026 | 17,000.00 |
| Dec 31, 2025 | 685,000.00 |
| Dec 31, 2025 | 685,000.00 |
| Sep 30, 2025 | -177,000.00 |
| Sep 30, 2025 | -177,000.00 |
| Jun 30, 2025 | 177,000.00 |
| Jun 30, 2025 | 177,000.00 |
| Dec 31, 2024 | 100.00 Mn |
| Dec 31, 2024 | 100.00 Mn |
| Jun 30, 2024 | 67.25 Mn |
| Jun 30, 2024 | 67.25 Mn |
| Mar 31, 2024 | 139,000.00 |
| Mar 31, 2024 | 139,000.00 |
| Dec 31, 2023 | -351,000.00 |
| Dec 31, 2023 | -351,000.00 |
| Sep 30, 2023 | 216,000.00 |
| Sep 30, 2023 | 216,000.00 |